Trailing-twelve-month (TTM) revenue is $10.21 Million with a year-over-year growth of +60.26%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,344,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $2,550,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q1 FY2026Period ended 2026-03-31 | $2,696,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15 |
| Q2 FY2026Period ended 2026-06-30 | $2,625,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $10,215,000 |
Current P/S: $25,268,756 market capitalization ÷ $10,215,000 TTM revenue = 2.47x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:55:23.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $2.63M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:05:54.864Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Other Revenues | $14,000 |
$10.21M
$10.21 Million
+60.26%
vs. $6.37M a year ago (TTM)
(6.18%)
5 Year compound annual growth rate
1 Year
+60.26%
3 Year
+6.33%
5 Year
(6.18%)
10 Year
+17.48%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.77M | +$3.86M | +98.57% |
| 2024 | $3.91M | +$126,000 | +3.33% |
| 2023 | $3.79M | ($10.10M) | (72.72%) |
| 2022 | $13.88M | +$1.49M | +12.01% |
| 2021 | $12.39M | ($1.61M) | (11.52%) |
| 2020 |
TTM Growth
+60.26%
3-Year CAGR
+6.33%
5-Year CAGR
(6.18%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $14.01M |
| +$2.38M |
| +20.49% |
| 2019 | $11.63M | +$5.50M | +89.86% |
| 2018 | $6.12M | +$3.51M | +134.53% |
| 2017 | $2.61M | +$502,690 | +23.84% |
| 2016 | $2.11M | +$405,688 | +23.83% |
